Chromogranin A regulates renal function by triggering Weibel-Palade body exocytosis

Journal of the American Society of Nephrology

Volumn 20, Issue 7, 2009, Pages 1623-1632

  Chen, Yuqing ^a,f   Mahata, Manjula ^a   Rao, Fangwen ^a   Khandrika, Srikrishna ^a   Courel, Maite ^a   Fung, Maple M ^a   Zhang, Kuixing ^a   Stridsberg, Mats ^d   Ziegler, Michael G ^a   Hamilton, Bruce A ^a   Lipkowitz, Michael S ^e   Taupenot, Laurent ^a   Nievergelt, Caroline ^a   Mahata, Sushil K ^a,c   O'Connor, Daniel T ^a,b,c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d UPPSALA UNIVERSITY   (Sweden)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN A; ENDOTHELIN 1; TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; EXOCYTOSIS; FEMALE; HAPLOTYPE; HUMAN; IN VIVO STUDY; KIDNEY DISEASE; KIDNEY FUNCTION; MALE; MESANGIUM CELL; PRIORITY JOURNAL; RENOVASCULAR HYPERTENSION; RISK FACTOR; WEIBEL PALADE BODY;

EID: 67649785347     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2008111148     Document Type: Article

References (44)

1. Banks P, Helle K: The release of protein from the stimulated adrenal medulla. Biochem J 97: 40C-41C, 1965
2. O'Connor DT: Plasma chromogranin A: Initial studies in human hypertension. Hypertension 7: I76-I79, 1985
3. Ceconi C, Ferrari R, Bachetti T, Opasich C, Volterrani M, Colombo B, Parrinello G, Corti A: Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality. Eur Heart J 23: 967-974, 2002 (Pubitemid 35203876)
4. Hsiao R, Mezger M, O'Connor D: Chromogranin A in uremia: Progressive retention of immunoreactive fragments. Kidney Int 37: 955-964, 1990 (Pubitemid 20089229)
5. Salem R, Cadman P, Chen Y, Rao F, Wen G, Hamilton B, Rana B, Smith D, Stridsberg M, Ward H, Mahata M, Mahata S, Bowden D, Hicks P, Freedman B, Schork N, O'Connor DT: Chromogranin A polymorphisms are associated with hypertensive renal disease. J Am Soc Nephrol 19: 600-614, 2008 (Pubitemid 351355404)
6. Lillie EO, Mahata M, Khandrika S, Rao F, Bundey RA, Wen G, Chen Y, Taupenot L, Smith DW, Mahata SK, Ziegler MG, Cockburn M, Schork NJ, O'Connor DT: Heredity of endothelin secretion: human twin studies reveal the influence of polymorphism at the chromogranin A locus, a novel determinant of endothelial function. Circulation 115: 2282-2291, 2007 (Pubitemid 46685896)
7. Benigni A: Defining the role of endothelins in renal pathophysiology on the basis of selective and unselective endothelin receptor antagonist studies. Curr Opin Nephrol Hypertens 4: 349-353, 1995
8. Goddard J, Johnston NR, Hand MF, Cumming AD, Rabelink TJ, Rankin AJ, Webb DJ: Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: A comparison of selective and combined endothelin receptor blockade. Circulation 109: 1186-1193, 2004 (Pubitemid 38332625)
9. Ong AC, Jowett TP, Firth JD, Burton S, Kitamura M, Fine LG: Human tubular-derived endothelin in the paracrine regulation of renal interstitial fibroblast function. Exp Nephrol 2: 134, 1994 (Pubitemid 24155114)
10. Wrana JL, Attisano L, Carcamo J, Zentella A, Doody J, Laiho M, Wang XF, Massague J: TGFβ signals through a heteromeric protein kinase receptor complex. Cell 71: 1003-1014, 1992
11. Rao F, Wessel J, Wen G, Zhang L, Rana BK, Kennedy BP, Greenwood TA, Salem RM, Chen Y, Khandrika S, Hamilton BA, Smith DW, Holstein-Rathlou NH, Ziegler MG, Schork NJ, O'Connor DT: Renal albumin excretion: Twin studies identify influences of heredity, environment, and adrenergic pathway polymorphism. Hypertension 49: 1015-1031, 2007 (Pubitemid 351664306)
12. Chen Y, Rao F, Rodriguez-Flores JL, Mahapatra NR, Mahata M, Wen G, Salem RM, Shih PA, Das M, Schork NJ, Ziegler MG, Hamilton BA, Mahata SK, O'Connor DT: Common genetic variants in the chromogranin A promoter alter autonomic activity and blood pressure. Kidney Int 74: 115-125, 2008 (Pubitemid 351841890)
13. O'Connor DT, Zhu G, Rao F, Taupenot L, Fung MM, Das M, Mahata SK, Mahata M, Wang L, Zhang K, Greenwood TA, Shih PA, Cockburn MG, Ziegler MG, Stridsberg M, Martin NG, Whitfield JB: Heritability and genome-wide linkage in US and Australian twins identify novel genomic regions controlling chromogranin A: Implications for secretion and blood pressure. Circulation 118: 247-257, 2008
14. Stridsberg M, Eriksson B, Oberg K, Janson ET: A panel of 11 regionspecific radioimmunoassays for measurements of human chromogranin A. Regul Pept 117: 219-227, 2004 (Pubitemid 38121658)
15. Wen G, Mahata SK, Cadman P, Mahata M, Ghosh S, Mahapatra NR, Rao F, Stridsberg M, Smith DW, Mahboubi P, Schork NJ, O'Connor DT, Hamilton BA: Both rare and common polymorphisms contribute functional variation at CHGA, a regulator of catecholamine physiology. Am J Hum Genet 74: 197-207, 2004 (Pubitemid 38168608)
16. Amann K, Rump LC, Simonaviciene A, Oberhauser V, Wessels S, Orth SR, Gross ML, Koch A, Bielenberg GW, Van Kats JP, Ehmke H, Mall G, Ritz E: Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats. J Am Soc Nephrol 11: 1469-1478, 2000 (Pubitemid 30483463)
17. Campese VM, Kogosov E: Renal afferent denervation prevents hypertension in rats with chronic renal failure. Hypertension 25: 878-882, 1995
18. Converse RL Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, Victor RG: Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 327: 1912-1918, 1992 (Pubitemid 23006966)
19. DiBona GF, Sawin LL: Effect of renal nerve stimulation on NaCl and H2O transport in Henle's loop of the rat. Am J Physiol 243: F576-F580, 1982 (Pubitemid 13167132)
20. Hansen J, Victor RG: Direct measurement of sympathetic activity: New insights into disordered blood pressure regulation in chronic renal failure. Curr Opin Nephrol Hypertens 3: 636-643, 1994
21. Kim T, Loh YP: Chromogranin A: A surprising link between granule biogenesis and hypertension. J Clin Invest 115: 1711-1713, 2005 (Pubitemid 40979709)
22. Mahapatra NR, O'Connor DT, Vaingankar SM, Hikim AP, Mahata M, Ray S, Staite E, Wu H, Gu Y, Dalton N, Kennedy BP, Ziegler MG, Ross J, Mahata SK: Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog. J Clin Invest 115: 1942-1952, 2005 (Pubitemid 40979734)
23. Aardal S, Helle KB, Elsayed S, Reed RK, Serck-Hanssen G: Vasostatins, comprising the N-terminal domain of chromogranin A, suppress tension in isolated human blood vessel segments. J Neuroendocrinol 5: 405-412, 1993 (Pubitemid 23243499)
24. Helle KB, Serck-Hanssen G, Aardal S: Functional aspects of the adrenal medullary chromogranins. Neurochem Int 22: 353-360, 1993 (Pubitemid 23087301)
25. Tota B, Quintieri AM, Di Felice V, Cerra MC: New biological aspects of chromogranin A-derived peptides: Focus on vasostatins. Comp Biochem Physiol A Mol Integr Physiol 147: 11-18, 2007 (Pubitemid 46467439)
26. Belloni D, Scabini S, Foglieni C, Veschini L, Giazzon A, Colombo B, Fulgenzi A, Helle K, Ferrero M, Corti A, Ferrero E: The vasostatin-I fragment of chromogranin A inhibits VEGF-induced endothelial cell proliferation and migration. FASEB J 21: 3052-3062, 2007 (Pubitemid 47565526)
27. Newby AC, Henderson AH: Stimulus-secretion coupling in vascular endothelial cells. Annu Rev Physiol 52: 661-674, 1990 (Pubitemid 20103561)
28. Schluter T, Bohnensack R: Serotonin-induced secretion of von Willebrand factor from human umbilical vein endothelial cells via the cyclic AMP-signaling systems independent of increased cytoplasmic calcium concentration. Biochem Pharmacol 57: 1191-1197, 1999 (Pubitemid 29171695)
29. Maricq AV, Peterson AS, Brake AJ, Myers RM, Julius D: Primary structure and functional expression of the 5HT3 receptor, a serotoningated ion channel. Science 254: 432-437, 1991 (Pubitemid 21917361)
30. Nitta K, Uchida K, Yumura W, Nihei H: Characterization of the glomerular endothelial cell in culture. Nippon Jinzo Gakkai Shi 35: 887-891, 1993
31. Marsden PA, Dorfman DM, Collins T, Brenner BM, Orkin SH, Ballermann BJ: Regulated expression of endothelin 1 in glomerular capillary endothelial cells. Am J Physiol 261: F117-F125, 1991
32. Jain R, Shaul PW, Borok Z, Willis BC: Endothelin-1 induces alveolar epithelial-mesenchymal transition through endothelin type A receptor- mediated production of TGF-β1. Am J Respir Cell Mol Biol 37: 38-47, 2007 (Pubitemid 46999535)
33. Mosley C, Taupenot L, Biswas N, Taulane J, Olson N, Vaingankar S, Wen G, Schork N, Ziegler M, Mahata S, O'Connor D: Biogenesis of the secretory granule: Chromogranin A coiled-coil structure results in unusual physical properties and suggests a mechanism for granule core condensation. Biochemistry 46: 10999-11012, 2007 (Pubitemid 47463051)
34. Akis N, Madaio MP: Isolation, culture, and characterization of endothelial cells from mouse glomeruli. Kidney Int 65: 2223-2227, 2004 (Pubitemid 38670008)
35. Stridsberg M: Measurements of chromogranins and chromograninrelated peptides by immunological methods. Adv Exp Med Biol 482: 319-327, 2000 (Pubitemid 32174541)
36. Stridsberg M, Angeletti RH, Helle KB: Characterisation of N-terminal chromogranin A and chromogranin B in mammals by region-specific radioimmunoassays and chromatographic separation methods. J Endocrinol 165: 703-714, 2000 (Pubitemid 30407699)
37. Stridsberg M, Oberg K, Li Q, Engstrom U, Lundqvist G: Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours. J Endocrinol 144: 49-59, 1995
38. Agodoa LY, Appel L, Bakris GL, Beck G, Bourgoignie J, Briggs JP, Charleston J, Cheek D, Cleveland W, Douglas JG, Douglas M, Dowie D, Faulkner M, Gabriel A, Gassman J, Greene T, Hall Y, Hebert L, Hiremath L, Jamerson K, Johnson CJ, Kopple J, Kusek J, Lash J, Lea J, Lewis JB, Lipkowitz M, Massry S, Middleton J, Miller ER III, Norris K, O'Connor D, Ojo A, Phillips RA, Pogue V, Rahman M, Randall OS, Rostand S, Schulman G, Smith W, Thornley-Brown D, Tisher CC, Toto RD, Wright JT Jr, Xu S: Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: A randomized controlled trial. JAMA 285: 2719-2728, 2001 (Pubitemid 32525368)
39. Buetow KH, Edmonson M, MacDonald R, Clifford R, Yip P, Kelley J, Little DP, Strausberg R, Koester H, Cantor CR, Braun A: Highthroughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc Natl Acad Sci U S A 98: 581-584, 2001 (Pubitemid 32105085)
40. Nievergelt CM, Libiger O, Schork NJ: Generalized analysis of molecular variance. PLoS Genet 3: e51, 2007 (Pubitemid 46683463)
41. Almasy L, Blangero J: Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62: 1198-1211, 1998 (Pubitemid 28199022)
42. Halperin E, Eskin E: Haplotype reconstruction from genotype data using Imperfect Phylogeny. Bioinformatics 20: 1842-1849, 2004 (Pubitemid 39199048)
43. Barrett JC, Fry B, Maller J, Daly MJ: Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265, 2005 (Pubitemid 40202029)
44. Do KA, Broom BM, Kuhnert P, Duffy DL, Todorov AA, Treloar SA, Martin NG: Genetic analysis of the age at menopause by using estimating equations and Bayesian random effects models. Stat Med 19: 1217-1235, 2000 (Pubitemid 30265933)